Cell & Gene Therapy

An experienced partner for your Cell & Gene Therapy innovation

With so many stakeholders in the field of cell and gene therapy, it’s essential to partner with an experienced team that can support your trials to ensure efficiency, compliance and safety. Now, organizations of all sizes can meet the future with confidence.

Expert guidance and deep intel to achieve your goals and drive the future of health

The recent successes of approved cellular and gene therapies have resulted in a surge of interest by biopharmaceutical developers. In fact, the gene therapy industry is expected to grow 30% year over year in R&D spending to help treat diverse therapeutic indications. With this growing market comes a variety of challenges that sponsors, CROs, and research sites must consider when running these trials. While this research provides the opportunity to uncover greater value for treatment, there should be no roadblocks along the way that impede the chances of trial success. Unfortunately though, there are.

So that’s exactly why we created our cell and gene therapy solutions: to help organizations bring life-changing therapies to patients who need them most. We do this by helping sponsors and CROs identify hard-to-find patient populations, reduce their exposure to risk, and increase the overall value of the asset being studied.

Talk with our team

3,000

Deep relationships with 3,000 sites well-known for C&GT research

5,000

Expertise in reviewing more than 5,000 cell or gene therapy clinical trials

What you can expect when working with WCG’s cell and gene therapy specialists

There’s a lot to plan for in your clinical trial, and it’s normal for uncertainties to arise. By partnering with WCG, we’ll help you make informed and confident decisions via the culmination of six best-of-breed services. When you choose to work with WCG, you can choose to leverage our expertise and operational prowess for all of these services, or a few of them based on your needs. Whichever route you take, our expertise will position you for great success.

Protocol Planning

Work with a team of 950 experts who evaluate endpoints, sample size, statistical analysis plan, study procedures, and I/E criteria. Their insights will enable more informed decision making.

IBC Review and Administration

Efficient, thorough review by the leaders in IRB and IBC administration. Since 2000, we’ve reviewed 98% of all cell or gene therapy trials: more than 5,000 trials total.

Site Identification and Feasibility

Know which research sites are most likely to enroll participants for your trial with our performance data on 160k global PIs.

Site Training

Obtain automated crediting for completed training, eliminating redundancy and saving your sites more than 200 hours on each study.

Data Monitoring Committee

Enhance trial integrity with un-blinded “easy to evaluate” data package by tapping into our network of more than 950 medical, statistical and safety experts.

Our footprint across cell and gene therapy is expansive

Knowledge and experience that is proven

WCG IRB has reviewed 98% of all cell or gene therapy trials: more than 5,000 trials total.

Deep expertise in a broad variety of specialties

Oncology
Cardiovascular
Diabetes
Rare and Ultra-Rare Diseases
CNS
Retinal

Guidance from world-renowned partners in research

With our partners InformedDNA and Inspire, we’re helping tackle the challenges of identifying, recruiting, and managing patients in clinical trials.

Featured experts that will guide your research strategy from start to finish

Daniel Kavanagh, PhD, RAC

Senior Scientific Advisory, Gene Therapy, Vaccines and Biologics, WCG

Sandy Smith, RN, MSN, AOCN

Senior Vice President, Clinical Solutions & Strategic Partnerships, WCG

Putting our clients at the center of everything we do

I’ve been working with the WCG team for the past few years, and we’ve truly appreciated the guidance, expertise, and assistance in navigating this ever-changing regulatory space. The team has been very helpful, professional and friendly, and WCG continues to lead and direct the process asking for our feedback every step of the way.”
Clinical Project Manager, Biopharma Organization